Correlation Between PT Semen and FSD Pharma
Can any of the company-specific risk be diversified away by investing in both PT Semen and FSD Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PT Semen and FSD Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PT Semen Indonesia and FSD Pharma Class, you can compare the effects of market volatilities on PT Semen and FSD Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PT Semen with a short position of FSD Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of PT Semen and FSD Pharma.
Diversification Opportunities for PT Semen and FSD Pharma
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between PSGTF and FSD is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding PT Semen Indonesia and FSD Pharma Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FSD Pharma Class and PT Semen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PT Semen Indonesia are associated (or correlated) with FSD Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FSD Pharma Class has no effect on the direction of PT Semen i.e., PT Semen and FSD Pharma go up and down completely randomly.
Pair Corralation between PT Semen and FSD Pharma
If you would invest 8.99 in FSD Pharma Class on September 17, 2024 and sell it today you would earn a total of 0.00 from holding FSD Pharma Class or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 1.56% |
Values | Daily Returns |
PT Semen Indonesia vs. FSD Pharma Class
Performance |
Timeline |
PT Semen Indonesia |
FSD Pharma Class |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
PT Semen and FSD Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PT Semen and FSD Pharma
The main advantage of trading using opposite PT Semen and FSD Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PT Semen position performs unexpectedly, FSD Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FSD Pharma will offset losses from the drop in FSD Pharma's long position.PT Semen vs. CRH PLC ADR | PT Semen vs. Vulcan Materials | PT Semen vs. Martin Marietta Materials | PT Semen vs. UltraTech Cement Limited |
FSD Pharma vs. Benchmark Botanics | FSD Pharma vs. Speakeasy Cannabis Club | FSD Pharma vs. City View Green | FSD Pharma vs. Ravenquest Biomed |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |